RETROSPECTIVE STUDY OF THE IMPACT OF ANTIRETROVIRAL THERAPY ON HIV/AIDS MORTALITY RATES

RI ABBASI; JH SHAIKH; B GHAFAR; R ZAREEN; T ZAFAR; A KUMAR

doi:10.54112/bcsrj.v2023i1.369

Authors

RI ABBASI Fellow Infectious Diseases, Shaukat Khanum Lahore, Pakistan
JH SHAIKH Department of Physiology, Liaquat University of Medical & Health Science (LUMHS), Pakistan
B GHAFAR Department of Biochemistry, Liaquat University of Medical & Health Science (LUMHS), Pakistan
R ZAREEN Department of Physiology, Liaquat University of Medical & Health Science (LUMHS), Pakistan
T ZAFAR Department of Physiology, Liaquat University of Medical & Health Science (LUMHS), Pakistan
A KUMAR MBBS Student, Liaquat University of Medical & Health Science (LUMHS), Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.369

Keywords:

HIV/AIDS, antiretroviral therapy, medication adherence, CD4 count, viral load, mortality rates.

Abstract

Antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal disease to a manageable chronic condition. The correlation between adherence to ART regimens, immunological and virological markers, and mortality rates among patients with HIV/AIDS necessitates ongoing research. In this retrospective study, we reviewed the medical records of 120 HIV/AIDS patients treated with ART at a tertiary care center. We categorized patients into five ART regimens, assessed reported adherence, and analyzed the corresponding immunological and virological parameters. Furthermore, we evaluated the impact of these factors on mortality rates. The patient distribution was approximately uniform across the five ART regimens. Most patients (60%) demonstrated high adherence to their prescribed regimen. The average CD4 count was 436.83 cells/mm³, and the mean viral load was 73,950 copies/mL. High adherence levels were significantly associated with increased CD4 counts and reduced viral loads. Furthermore, improved immunological and virological outcomes and high adherence levels correlated with decreased mortality rates among the study population. Our study reinforces the importance of adherence to ART regimens in managing HIV/AIDS effectively and reducing associated mortality rates. It underscores the need for individualized regimen selection to optimize patient outcomes and for continued efforts to enhance adherence. Future research should explore strategies to improve adherence and understand the individual variations in response to different ART regimens.

Downloads

Download data is not yet available.

References

Avci, G., Sheppard, D. P., Tierney, S. M., Kordovski, V. M., Sullivan, K. L., and Woods, S. P. (2020). A systematic review of prospective memory in HIV disease: From the laboratory to daily life. Prospective Memory in Clinical Populations, 118-150.

B Nachega, J., C Marconi, V., U van Zyl, G., M Gardner, E., Preiser, W., Y Hong, S., J Mills, E., and Gross, R. (2011). HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders) 11, 167-174.

Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., and Moss, A. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. Aids 15, 1181-1183.

Deeks, S. G., Lewin, S. R., and Havlir, D. V. (2013). The end of AIDS: HIV infection as a chronic disease. The lancet 382, 1525-1533.

Ghidei, L., Simone, M. J., Salow, M. J., Zimmerman, K. M., Paquin, A. M., Skarf, L. M., Kostas, T. R., and Rudolph, J. L. (2013). Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs & aging 30, 809-819.

Global, H. (2021). AIDS statistics—2019 fact sheet [https://www. unaids. org/en/resources/fact-sheet]. Accessed.

Katlama, C., Deeks, S. G., Autran, B., Martinez-Picado, J., Van Lunzen, J., Rouzioux, C., Miller, M., Vella, S., Schmitz, J. E., and Ahlers, J. (2013). Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. The Lancet 381, 2109-2117.

Leyro, T. M., Vujanovic, A. A., and Bonn-Miller, M. O. (2015). Examining associations between cognitive-affective vulnerability and HIV symptom severity, perceived barriers to treatment adherence, and viral load among HIV-positive adults. International journal of behavioral medicine 22, 139-148.

Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., Kingsley, L. A., Todd, J. A., Saah, A. J., and Detels, R. (1997). Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Annals of internal medicine 126, 946-954.

Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P. d., Monforte, A. d. A., Knysz, B., Dietrich, M., Phillips, A., and Lundgren, J. D. (2003). Decline in the AIDS and death rates in the EuroSIDA study: an observational study. The Lancet 362, 22-29.

Ortego, C., Huedo-Medina, T. B., Llorca, J., Sevilla, L., Santos, P., Rodríguez, E., Warren, M. R., and Vejo, J. (2011). Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS and Behavior 15, 1381-1396.

Picat, M.-Q., Lewis, J., Musiime, V., Prendergast, A., Nathoo, K., Kekitiinwa, A., Nahirya Ntege, P., Gibb, D. M., Thiebaut, R., and Walker, A. S. (2013). Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. PLoS medicine 10, e1001542.

Zash, R. M., Souda, S., Leidner, J., Binda, K., Hick, C., Powis, K., Makhema, J., Mmalane, M., Essex, M., and Lockman, S. (2017). High proportion of deaths attributable to HIV among postpartum women in Botswana despite widespread uptake of antiretroviral therapy. AIDS patient care and STDs 31, 14-19.